Skip to main content
logo
CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.000377 (-5.91%)
At close: Oct 16, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
011269236223
Market Cap Growth
-90.61%-87.73%-83.24%-70.89%6.05%-
Enterprise Value
1791470236-
Last Close Price
0.010.07120.0022000.0020540.6019820.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--0.26-6.081574.06-21.45-29.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.52-0.13-0.8367.45-0.06-
Net Debt / Equity Ratio
-0.490.160.8932.60-0.020.14
Net Debt / EBITDA Ratio
-0.850.050.11-0.20--
Quick Ratio
0.030.180.440.430.0211.20
Current Ratio
0.050.300.500.561.3813.88
Return on Assets (ROA)
-279.03%-253.00%-178.66%-20.20%-1.63%-
Return on Capital Employed (ROCE)
59.30%366.00%1355.00%-474.00%-25.00%-0.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20919.93%-1409.96%-72.13%-10.61%-0.28%-0.24%
Buyback Yield / Dilution
-1854.15%-16477.89%----